Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Palomaki

Showing results (211-220 of 275) with videos related to

Pageof 28
Sort By:
Journal of Medical Screening|January 2, 2013
Feasibility of using plasma rather than serum in first and second trimester multiple marker Down's syndrome screeningGeralyn M Lambert-Messerlian, Glenn E Palomaki, Elizabeth E Eklund, et al.
Prenatal Diagnosis|July 1, 1997
Comparison of 12 assays for detecting hCG and related molecules in urine samples from Down syndrome pregnanciesL A Cole, L H Kellner, T Isozaki, et al.
Prenatal Diagnosis|October 21, 2009
Early onset preeclampsia and second trimester serum markersGeralyn M Lambert-Messerlian, Glenn E Palomaki, Louis M Neveux, et al.
Pregnancy Hypertension|June 25, 2015
Use of first or second trimester serum markers, or both, to predict preeclampsiaGeralyn Lambert-Messerlian, Elizabeth E Eklund, Edward K Chien, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 20, 2007
Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarctionPeter A Kavsak, Andrew R MacRae, Alice M Newman, et al.
Fertility and Sterility|April 26, 2020
Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiencyKutluk H Oktay, Giuliano Bedoschi, Shari B Goldfarb, et al.
Prenatal Diagnosis|October 19, 2005
Integrated serum screening for Down syndrome in primary obstetric practiceGeorge J Knight, Glenn E Palomaki, Louis M Neveux, et al.
British Journal of Obstetrics and Gynaecology|April 1, 1988
Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndromeN J Wald, H S Cuckle, J W Densem, et al.
Prenatal Diagnosis|February 19, 1998
Levels of urinary beta-core fragment, total oestriol, and the ratio of the two in second-trimester screening for Down syndromeL H Kellner, J A Canick, G E Palomaki, et al.
Clinical Chemistry|February 1, 2003
Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancyAntonio Farina, Erik S LeShane, Geralyn M Lambert-Messerlian, et al.
Pageof 28

Showing results (211-220 of 275) with videos related to

Sort By:
Pageof 28
Journal of Medical Screening|January 2, 2013
Feasibility of using plasma rather than serum in first and second trimester multiple marker Down's syndrome screeningGeralyn M Lambert-Messerlian, Glenn E Palomaki, Elizabeth E Eklund, et al.
Prenatal Diagnosis|July 1, 1997
Comparison of 12 assays for detecting hCG and related molecules in urine samples from Down syndrome pregnanciesL A Cole, L H Kellner, T Isozaki, et al.
Prenatal Diagnosis|October 21, 2009
Early onset preeclampsia and second trimester serum markersGeralyn M Lambert-Messerlian, Glenn E Palomaki, Louis M Neveux, et al.
Pregnancy Hypertension|June 25, 2015
Use of first or second trimester serum markers, or both, to predict preeclampsiaGeralyn Lambert-Messerlian, Elizabeth E Eklund, Edward K Chien, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 20, 2007
Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarctionPeter A Kavsak, Andrew R MacRae, Alice M Newman, et al.
Fertility and Sterility|April 26, 2020
Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiencyKutluk H Oktay, Giuliano Bedoschi, Shari B Goldfarb, et al.
Prenatal Diagnosis|October 19, 2005
Integrated serum screening for Down syndrome in primary obstetric practiceGeorge J Knight, Glenn E Palomaki, Louis M Neveux, et al.
British Journal of Obstetrics and Gynaecology|April 1, 1988
Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndromeN J Wald, H S Cuckle, J W Densem, et al.
Prenatal Diagnosis|February 19, 1998
Levels of urinary beta-core fragment, total oestriol, and the ratio of the two in second-trimester screening for Down syndromeL H Kellner, J A Canick, G E Palomaki, et al.
Clinical Chemistry|February 1, 2003
Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancyAntonio Farina, Erik S LeShane, Geralyn M Lambert-Messerlian, et al.
Pageof 28